dactinomycin and Mixed Tumor, Mullerian

dactinomycin has been researched along with Mixed Tumor, Mullerian in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argenta, PA; Dusenbery, KE; Judson, PL; Potish, RA1

Reviews

1 review(s) available for dactinomycin and Mixed Tumor, Mullerian

ArticleYear
On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Abdominal Neoplasms; Antineoplastic Agents; Brachytherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Hysterectomy; Ifosfamide; Intestinal Obstruction; Leiomyosarcoma; Life Tables; Mixed Tumor, Mullerian; Neoplasm Staging; Pelvic Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma; Survival Analysis; Survival Rate; Treatment Failure; Uterine Neoplasms

2005